Taiwan FDA registration 7d1ec4026d45011ff02a8ef561f1023c

"Siloa" Respiratory Fusion Cell Virus and Adenovirus Rapid Test Reagent (Unsterilized)

TW: "西羅亞" 呼吸道融合細胞病毒及腺病毒快速檢驗試劑 (未滅菌)

Taiwan·Risk Class 1·HANGZHOU ALLTEST BIOTECH CO., LTD.·Registered Apr 28, 2021 – Apr 28, 2026Expired

Registration details

Analysis ID: 7d1ec4026d45011ff02a8ef561f1023c
Customs Code: DHA09600451401

Company information

Manufacturer: HANGZHOU ALLTEST BIOTECH CO., LTD.
Manufacturer Country: China
Authorized Representative: Siloam Biotech Co., Ltd.

Product details

Intended Use: It is limited to the first-level identification scope of the "Adenovirus Serum Reagent (C.3020)" and "Respiratory Fusion Cell Virus Serum Reagent (C.3480)" in the Classification and Grading Management Measures for Medical Devices.
Product Type (Level 1): C Immunology and microbiology
Product Type (Level 2): C.3480 呼吸道融合細胞病毒血清試劑;; C.3020 腺病毒血清試劑
Import Information: Input;; Chinese goods

Dates and status

Registration Date: Apr 28, 2021
Expiry Date: Apr 28, 2026

About this record

Access comprehensive regulatory information for "Siloa" Respiratory Fusion Cell Virus and Adenovirus Rapid Test Reagent (Unsterilized) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 7d1ec4026d45011ff02a8ef561f1023c and manufactured by HANGZHOU ALLTEST BIOTECH CO., LTD.. The authorized representative in Taiwan is Siloam Biotech Co., Ltd..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.